Will the Phase 3 trial "Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis" reach primary completion on or before Feb 5, 2028?

Resolves Yes if ClinicalTrials.gov record NCT06870409 (University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)) shows an actual primary completion date on or before Feb 5, 2028. Registered date at generation: Feb 5, 2028.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   Feb 6, 2028, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.